Aims and Background: Protein O-linked glycosylation is regulated in vivo by the concentration of hexosamine substrates. Calorie restriction (60% of ad libitum intake) for 20 days causes decreased UDP-N-acetylhexosamine levels and increased insulin-mediated glucose transport in rat skeletal muscle. Conversely, prolonged incubation (19 h) of muscle with O-(2-acetamido-2-deoxy-
estimated that a small fraction of the glucose (3-5%) that enters cells is directed through the HBP (Marshall et al. 1991 ). Fructose-6-phosphate and glutamine are converted to glucosamine-6-phosphate by glutamine/ fructose-6-phosphate amidotransferase (GFAT), the first-and rate-limiting step in the HBP. UDP-Nacetylglucosamine (UDP-GlcNAc), an endproduct of the HBP, serves as the substrate for O-glucosamine transferase (OGT) in the O-linked glycosylation of proteins on specific serine and threonine residues (Hart 1997) . O-GlcNAcase is a nucleocytoplasmic enzyme and the neutral glycosidase that cleaves O-GlcNAc from the protein, a process that is analogous to the dephosphorylation function of a phosphatase. Thus, O-GlcNAcylation is a dynamic process of transfer and removal of O-GlcNAc and has been detected in normal and abnormal conditions. Marshall et al. (1991) first described the relationship between the HBP and insulin-stimulated glucose uptake in cultured adipocytes. Subsequently, a number of conditions which have increased flux through the HBP, e.g. prolonged hyperglycemia (Rossetti et al. 1990) , increasing plasma levels of glucosamine (Yki-Jä rvinen et al. 1998) , and transgenic mice overexpressing GFAT (Hebert et al. 1996) , have been demonstrated to also be characterized by insulin resistance. Several studies have provided evidence that alterations in protein O-GlycNAcylation can influence insulin action. Vosseller et al. (2002) reported that prolonged (19 h) incubation of 3T3-L1 adipocytes in O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenyl-carbamate (PUGNAc), a potent inhibitor of N-acetyl-b-d-glucosaminidase (O-GlcNAcase), induced extensive O-GlcNAcylation of proteins as well as insulin resistance for glucose uptake. Recently, we reported similar findings in rat epitrochlearis muscle: prolonged (19 h) incubation in PUGNAc elicited increased O-GlcNAcylation of multiple proteins identified using an antibody against b-O-linked N-acetylglucosamine. Furthermore, PUGNAc also induced a decrease in glucose transport with a physiologic insulin concentration (Arias et al. 2004) .
In contrast to interventions which lead to insulin resistance, calorie restriction (CR; consuming 60% of ad libitum, AL, intake) by rats or mice can increase insulin-stimulated glucose transport by skeletal muscle, and this effect can occur with only 20 days of CR (Cartee & Dean 1994 , Dean & Cartee 1996 , Gazdag et al. 1998 , Davidson et al. 2002 , McCurdy et al. 2003 . It would be important to identify the molecular processes that trigger the CR-induced increase in insulin sensitivity. Consistent with the apparent inverse relationship between HBP flux and insulin sensitivity, the CR-induced increase in insulin-stimulated glucose transport is accompanied by a reduction in skeletal muscle levels of UDP-N-acetylhexosamines (acetylglucosamine and acetylgalactosamine) (Gazdag et al. 2000) .
O-GlcNAcylation appears to be predominantly regulated by the cellular concentrations of UDPGlcNAc (Kreppel & Hart 1999) . In light of the CRinduced decline in UDP-GlcNAc levels in skeletal muscle (Gazdag et al. 2000) , in this study, our principal aim was to assess possible differences between calorie restricted and ad libitum rats in protein O-GlcNAcylation of skeletal muscle. In addition, to gain more insights into the link between protein O-GlcNAcylation and insulin action, we performed further research using PUGNAc with isolated skeletal muscle. Previous studies found that 19 h of incubation in PUGNAc induced insulin resistance in 3T3-L1 adipocytes (Vosseller et al. 2002) and skeletal muscle (Arias et al. 2004) . It seemed valuable to further examine the temporal relationship between PUGNAc's effects on protein O-GlcNAcylation and insulin-stimulated glucose transport. Accordingly, we assessed the effects of a shorter duration (8.5 h) of PUGNAc exposure on incubated rat skeletal muscle prior to measuring protein O-GlcNAcylation status and glucose transport. (Davidson et al. 2002) .
Methods

Materials
Step 1: Upon arrival at the animal facility, the rats were provided with chow and water ad libitum for an 1-week acclimatization period.
Step 2: Subsequently, individual baseline food intake was determined by allowing rats unlimited access to food for 1 week and measuring food intake corrected for spillage.
Step 3: Animals were then familiarized to a meal-feeding protocol for another week. The mealfeeding protocol consisted of providing rat chow in three 1.5-h periods over the course of each day.
Step 4: Following the familiarization period, the ad libitum (AL) rats were given 100% of their individual baseline intake for a period of 20 days, while the CR rats received 60% of their individual intake for 20 days as determined during the baseline period. Both groups received the same per cent allotment accordingly (35% at 06:00 h, 25% at 15:00 h, and 40% at 20:00 h). For experiment 1, animals received their 06:00 h meal on the experimental day, were transported from the animal facility to the laboratory at 10:00 h and were anaesthetized with an intraperitoneal injection of sodium pentobarbital [5 mg (100 g)
body wt] between 12:00 h and 14:00 h. Upon loss of pedal reflexes, plantaris muscles (fibre type composition: 15, 31, and 54%, for type I, type IIa, and type IIb, respectively) and liver were quickly excised, freeze-clamped and stored at )80°C until further processing.
Experiment 2 was performed to assess the effects of in vitro incubation of skeletal muscle with O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc), an inhibitor of the enzyme that catalyses removal of O-GlcNAc modifications from proteins. Male Wistar rats (1.5 month old) were obtained from Harlan (Indianapolis, IN, USA) and provided with Purina rat chow and water ad libitum. Upon arrival at the animal facility, the animals were acclimated to their surroundings for 2-3 days and fasted at 18:00 h on the night prior to each experiment.
For experiment 2, on the day of muscle dissections between 12:00 h and 14:00 h, the animals were anaesthetized with an intraperitoneal injection of sodium pentobarbital [5 mg (100 g) 
Muscle incubation and glucose transport
The protocol used for epitrochlearis incubation is similar to those previously described (Arias et al. 2004) , but modified for 8.5 h rather than 19 h PUGNAc exposure. Briefly, following dissection, muscles were incubated for 8 h in flasks containing 1.5 mL low glucose (5.5 mm) DMEM supplemented to contain 2.54 mm CaCl 2 and 25 mm NaHCO 3 . Flasks were placed in a shaking water bath at 35°C and continuously gassed with 95% O 2 /5% CO 2 throughout the experiment. After 4 h incubation, the media was discarded and replaced with fresh DMEM supplemented as described above.
Following the 8 h incubation in supplemented DMEM, muscles were rinsed in Krebs-Henseleit buffer (KHB) supplemented with 0.1% BSA, 2 mm sodium pyruvate, and 5 mm mannitol for sequential 20 min and 10 min periods at 30°C to rinse away glucose and DMEM. During the rinse steps, the KHB was supplemented with 0, 0.6, or 12 nm insulin. Muscles treated with PUGNAc in the initial incubation steps continued to be exposed to 100 lm PUGNAc during the subsequent rinse steps. Overall the PUGNAc-treated muscles were exposed to PUGNAc for a total duration of 8.5 h prior to incubation with 3-O-methyl-d-glucose.
Finally, muscles were incubated at 30°C for 15 min in 1.5 mL KHB containing 8 mM 3-O-methyl-d-glucose ([ 3 H]-3-MG; 0.5 mCi mmol )1 ) and 2 mm mann-
remained the same as in the preceding rinse steps (0, 0.6 or 12 nm insulin). Muscles were then rapidly blotted, trimmed, clamp frozen with aluminium tongs cooled to the temperature of liquid N 2 , and stored at )80°C until further processing.
Muscle preparation
Frozen muscles were weighed, transferred to pre-chilled glass tissue grinding tubes (Kontes) and homogenized in ice-cold lysis buffer (1 mL muscle )1 ) containing 20 mm Tris-HCl, pH 7.4, 150 mm NaCl, 1% NP-40 (v/v), 2 mm EDTA, 2 mm EGTA, 1 mm dithiothreitol, 2.5 mm sodium pyrophosphate, 10 mm sodium fluoride, 2 mm sodium vanadate, 20 mm b-glycerophosphate, 2 lm PUGNAc, 1 lg mL )1 leupeptin, 1 lg mL
pepstatin, 1 lg mL )1 aprotinin, and 2 mm phenylmethylsulfonyl fluoride. Homogenates were transferred to microfuge tubes, rotated for 1-2 h at 4°C and then centrifuged at 12 000 · g for 15 min to remove insoluble material. Following homogenization, plantaris muscle and liver samples from the calorie restriction experiment were processed for Western blotting while epitrochlearis muscle samples from the PUGNAc-incubation experiment were used for determination of glucose transport as well as for Western blotting. Supernatants were transferred to fresh microfuge tubes and duplicate 200 lL aliquots derived from epitrochlearis muscles were immediately used for scintillation counting.
[ 3 H]-3-MG uptake was determined as previously described (Davidson et al. 2002) . Protein concentrations of all supernatants were determined by the BCA method (Smith et al. 1985) .
Immunoblotting
Aliquots of supernatants were solubilized in SDS sample buffer, boiled for 3 min and subjected to 8-10% SDS-PAGE. Resolved proteins were transferred to nitrocellulose paper overnight at a constant current of 150 mA/ transfer apparatus in electrotransfer buffer (20 mm Tris, pH 8.0, 150 mm glycine, 0.025% SDS, 20% methanol). Nitrocellulose blots were blocked in TBST-HT (0.3% Tween-20 in tris-buffered saline, pH 7.5) for 1 h at room temperature and transferred to fresh TBST-HT with either the CTD110.6 or RL2 anti-O-linked N-acetylglucosamine antisera (1 : 1000) for 2 h at room temperature or overnight at 4°C. Blots were then washed and incubated in secondary antibody (goat antimouse IgM-HRP, CTD110.6; anti-mouse IgG-HRP, RL2; 1 : 5000) for 1 h at room temperature. Blots were washed of excess antibody, subjected to enhanced chemiluminescence, and immunoreactive protein was quantified by densitometry.
Statistical analysis
All data are expressed as mean AE SE. Differences between groups (AL vs. CR) for the calorie restriction experiment were evaluated by t-test. Differences between groups for the PUGNAc experiment (PUGNAc vs. no PUGNAc) were evaluated by paired t-test. Statistics were performed using SigmaSTAT (SPSS, Chicago, IL, USA). P £ 0.05 was considered statistically significant.
Results
O-linked glycosylation status of proteins from the plantaris muscle from experiment 1 (the calorie restriction study) was evaluated by Western blotting using two different monoclonal antibodies, CTD110.6 and RL2 (Fig. 1a) . Multiple protein bands were detected by CTD110.6 and RL2 antibodies and subsequently were quantitated by densitometry (Fig. 1b and c) . No significant differences were found between CR and AL in any of the detected protein bands using either antibody. In addition, we assessed the O-GlcNAcylation status of the liver of experiment 1 (CR and AL) using the CTD110.6 antibody (Fig. 2a) . Multiple protein bands were identified but no differences in O-GlcNAcylation were observed between the CR and AL groups (Fig. 2b) .
For experiment 2, incubation of epitrochlearis muscles with 100 lm PUGNAc for 8.5 h resulted in multiple protein bands demonstrating significantly increased immunoreactivity against the CTD110.6 antibody compared with paired muscles incubated without PUGNAc (Fig. 3a and b) . As expected, glucose transport increased with increasing insulin concentrations. However, incubation with PUGNAc for 8.5 h did not affect glucose transport with any insulin concentration (Fig. 4) .
Discussion
The most important findings from this study were, (1) CR did not cause a detectable difference between CR and AL rats for protein O-GlcNAcylation of insulinresponsive tissues, skeletal muscle and liver; and (2) PUGNAc-induced O-GlcNAcylation of skeletal muscle proteins preceded the development of insulin resistance.
Increased skeletal muscle insulin sensitivity is a hallmark of a moderate reduction in calorie consumption, having been documented in vivo with the euglycemic-hyperinsulinemic clamp of rats (Reaven et al. 1983) , in perfused rat hindlimb (Ivy et al. 1991) , and in isolated muscle preparations from rats and mice , Gazdag et al. 1999 , Dean & Cartee 2000 , McCurdy et al. 2003 . The effect is found rapidly, after only 20 days, in skeletal muscles of various fibre type composition, including the predominantly type I soleus (Gazdag et al. 1999) , predominantly type II-a flexor digitorum brevis (Gazdag et al. 1998) , and predominantly type II-b epitrochlearis , Gazdag et al. 1999 , Dean & Cartee 2000 , McCurdy et al. 2003 . Using the same CR protocol as in experiment 1, we previously found increased insulin sensitivity in the epitrochlearis concomitant with reduced hexosamine levels in the plantaris muscle (Gazdag et al. 2000) .
The endproducts of the HBP are UDP-N-acetylsugars which act as substrates for various transferases, including OGT. OGT activity is believed to be principally regulated by cellular hexosamine concentrations (Kreppel & Hart 1999) , although it is also susceptible to post-translational modifications which may alter its activity (Kreppel et al. 1997) Homogenates were subjected to 8% SDS-PAGE. Protein blots were probed with anti-O-GlcNAc (CTD110.6 and RL2) and visualized following ECL. Relative molecular weight standards are denoted. Protein bands were quantitated by densitometry and values from CR-treated animals are expressed relative to the mean value for the corresponding protein band in muscles from AL rats (mean AE SE; n ¼ 7 for AL, n ¼ 9 for CR) for (b) CTD110.6, and (c) RL2. cellular proteins (Vosseller et al. 2002 , Walgren et al. 2003 . In this context, the primary aim of this study was to examine whether the previously described CR-induced decrease in cellular hexosamines (Gazdag et al. 2000) was accompanied by an alteration in the protein OGlcNAcylation status in rat skeletal muscle.
We used two antibodies, CTD110.6 and RL2, which have been widely employed to detect O-linked glycosylation in cells and tissues (Patti et al. 1999 , Vosseller et al. 2002 , Walgren et al. 2003 , Arias et al. 2004 . Specifically, CTD110.6, which was generated against a synthetic glycopeptide with b-d-N-acetylglucosamine on an internal serine residue, recognizes O-GlcNAc with a beta-O-glycosidic linkage on both serine and threonine. In contrast, RL2 was generated against several O-GlcNAcylated proteins derived from the nuclear pore complex-lamina fraction of rat liver nuclear envelopes. Using these two antibodies, we were able to detect multiple protein bands. Several of the protein bands in skeletal muscle lysates were immunoreactive with both of the antibodies, suggesting the two antibodies may have recognized some of the same proteins. However, we were unable to detect differences in protein O-GlcNAcylation between skeletal muscles from CR compared with AL rats using either antibody. We also found no effect of CR on levels of O-GlcNAcylated proteins in liver. Based on the mechanism we originally hypothesized might lead to a CR-related effect on protein O-GlcNAcylation, i.e. as the result of CR-induced reduction in UDP-GlcNAc, we would have predicted a general decline in O-GlcNAc-modified proteins. However, the current results argue against a robust, global effect of CR on protein O-GlcNAcylation in skeletal muscle. There are several possible interpretations for the lack of any detectable CR-induced change in protein O-GlcNAcylation, including: (1) brief CR did not affect protein O-GlcNAcylation in skeletal muscle and liver, (2) CR affected O-GlcNAcylation of proteins with low abundance and, therefore, below the sensitivity of our assays; (3) CR affected proteins with O-GlcNAc motifs that are not recognized by the antibodies used; and/or (4) CR alters the O-GlcNAcylation of non-protein molecules (e.g. glycolipids). Other methods for detection of O-GlcNAcylation that do not rely on these antibodies (Roquemore et al. 1994) Recent studies have demonstrated that insulin resistance and increased protein O-GlycNAcylation can be induced by prolonged (19 h) incubation of skeletal muscle (Arias et al. 2004 ) and 3T3-L1 adipocytes (Vosseller et al. 2002) with PUGNAc, a potent inhibitor of O-GlcNAcase. In the current study, however, although protein O-GlcNAcylation in skeletal muscle was markedly increased by incubation with PUGNAc for 8.5 h, this treatment did not alter basal or insulinstimulated glucose transport. Taken together with our previous results (Arias et al. 2004) , these findings have important implications, because they indicate that a substantial increased in protein O-GlcNAcylation can precede PUGNAc-induced insulin resistance in skeletal muscle. The explanation for the delay between increased protein O-GlcNAcylation and induction of insulin resistance is unknown. Perhaps prolonged incubation with PUGNAc is required to achieve a sufficient level of O-GlcNAcylation of the specific proteins that lead to insulin resistance. Alternatively, prolonged PUGNAc exposure may induce insulin resistance indirectly through a relatively slow process, e.g. altered gene expression and protein abundance. Finally, although we believe this to be unlikely, it remains possible that PUGNAc-induced insulin resistance was unrelated to PUGNAc's well-established effect on O-GlyNAcylation of proteins. Further experiments will be needed to evaluate the potential importance of these suggested explanations.
In conclusion, we were unable to detect differences between CR and AL tissues (skeletal muscle or liver) for O-GlcNAcylation of proteins, although the UDPHexNAc levels in rat skeletal muscle are significantly lower for CR compared with AL rats (Gazdag et al. 2000) . Secondly, we found that the induction of O-GlcNAcylation in skeletal muscle by exposure to PUGNAc, a potent inhibitor of O-GlcNAcase, precedes PUGNAc's effects on insulin sensitivity. Using an in vivo experimental model (CR) that leads to increased insulin sensitivity in skeletal muscle (Davidson et al. 2002) , and an in vitro model (PUGNAc incubation) that leads to insulin resistance in skeletal muscle (Arias et al. 2004) , we have dissociated the effects on insulin action from immunologically detected changes in protein O-GlcNAcylation. These findings argue that the effect of brief CR on insulin sensitivity is unlikely to be the direct result of a marked, global change in muscle levels of O-GlcNAcylated proteins. Figure 4 Rate of 3-MG transport in paired muscles after 8.5 h incubation in the presence or absence of 100 lm PUGNAc. During the final 45 min of incubation, muscles were exposed to 0, 0.6 or 12 nm insulin. Data are mean AE SE (n ¼ 6 per group).
